A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure
Status: | Completed |
---|---|
Conditions: | Depression, Depression |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 55 |
Updated: | 8/11/2017 |
Start Date: | February 16, 2007 |
End Date: | June 8, 2007 |
A Cross-over Study to Evaluate the Effect of WELLBUTRIN XL on Intraocular Pressure in Healthy Volunteers
This study will be conducted in healthy volunteers to investigate the effect on intraocular
pressure of 2 weeks of treatment with 300mg WELLBUTRIN XL/day.
pressure of 2 weeks of treatment with 300mg WELLBUTRIN XL/day.
Inclusion Criteria:
- Healthy males or females.
- Non-smokers
- Agree to remain in the clinic for the time defined in the protocol.
- Normal ECG.
Exclusion Criteria:
- Any serious medical disorder or condition.
- Any history of an endocrine disorder.
- Any clinically significant laboratory abnormality.
- History of psychiatric illness.
- Any history of suicidal attempts or behavior.
- Risk factors for precipitation of angle closure glaucoma or elevated IOP.
- Inability to refrain from use of contact lenses during the study days, if correction
is required.
- Self-administered Beck Depression Inventory II scale total score greater than 9, and a
suicide question score of greater than zero.
- Current or past history of seizure disorder or brain injury (traumatic or
disease-related); or any condition which, in the opinion of the investigator,
predisposes to seizure - Women having a positive serum HCG pregnancy test at
screening, a positive urine pregnancy test before admission to the Unit during the
in-house periods, who are not willing to use acceptable methods of contraception or
who are lactating or planning to become pregnant within the three months following the
screening visit.
We found this trial at
1
site
Click here to add this to my saved trials